Search

ABSTRACT The synthesis and structural analysis of complexes derived from (E)‐N′‐(3,5‐di‐tert‐butyl‐2‐hydroxybenzylidene) isonicotino hydrazide (ITB ligand) were examined using multiple analytical techniques. These techniques included TGA, decomposition point determination, elemental analysis (CHN), spectroscopic (IR, NMR, mass spectrometry) analysis, magnetic susceptibility, conductivity, as well UV–Vis spectrum analysis, along with theoretical studies. Molar conductance values indicated that the Cd (II), Co (II), Cu (II), Ni (II), and Zn (II) complexes are non‐electrolytes in fresh DMSO solutions, with conductance values ranging from 8.5 to 14.35 Ω−1 cm2 mol−1. IR spectra suggested which the ligand coordinates through the metal ions in a tridentate fashion, utilizing the (N & O) donor sites from the (CN & CO & CO) groups in the hydroxybenzylidene moiety. Analytical data from solution complexation, job's method suggested a 1:1 (metal:ligand) molar ratio. The stability order of the complexes was determined as ITBCo > ITBCu > ITBNi > ITBZn > ITBCd, consistent with the stability constant (Kf) values. The pH profile indicated that the studied complexes exhibit stability upon a wide pH scale, typically between (pH = 4:10). Magnetic and electronic spectral analyses helped deduce the ligand coordination abilities and the geometric structures of the complexes. In vitro (antimicrobial & anticancer) performances of the studied complexes were tested versus various (microbial strains & cancer cell lines), revealing higher activity in the chelates assessed to the free (ITB) ligand. The antioxidant potential was also assessed using the DPPH assay. Finally, molecular docking was performed toward estimate the binding efficiency between various protein receptors and the compounds, with results aligning with the biological investigations. [ABSTRACT FROM AUTHOR]

[Display omitted] • Development of some new tripodal metal chelates and their structural elucidation. • Geometry optimization for structural confirmation. • Biomedical applications against microbes and carcinoma cell lines. • Docking approach for biomedical applications inspection. Direct condensation of 2-acetylferrocene with tris(2-aminoethyl)amine resulted in a novel tripodal imine ligand (L). Treatment of the metals' chlorides (Fe3+, Cr3+, Co2+, Ni2+, Cu2+, Mn2+, Cd2+, and Zn2+) with equimolar ratio of the tripodal imine ligand led to cleaned production of the equivalent mononuclear complexes. They are well characterized by different physicochemical analyzing tools such as CHN, FT-IR as well as electronic spectroscopy, mass spectrometry and TGA analyses. Furthermore, scanning electron microscope (SEM) study for the tested ligand as well as Cd(II) chelate proved that it was nanosized. The stoichiometry of the prepared metal chelates in solution confirm M:L is 1:1 ratio. The DFT calculations demonstrated that all metal complexes possess octahedral geometry in accordance with the experimentally deduced geometry. The MEP surface indicated the reactive regions of the compounds for electrophilic and nucleophilic attack. HOMO-LUMO analysis implies charge transfer interaction during complex formation. Quantum chemical reactivity parameters showed that the complexes are stable and the decomposition process into constituent elements does not occur. Morover, anti-pathogenic and anticancer activities were studied against different bacterial, fungal strains and selected cancer cell lines. The metal chelates show potent anti-microbial and anti-cancer activity than its tripodal imine ligand. Furthermore, MOE-docking of the title ligand, Cu(II) as well as Cd(II) chelate was studied with crystal structure of the antimalarial drug Amediaquine (3AOU), colon cancer antigen10 (2HQ6), breast cancer (3HB5) and gastrointestinal cancer (4IJO). [ABSTRACT FROM AUTHOR]

[Display omitted] • Synthesis of new-(((9H-purin-6-yl)imino)methyl)-4-bromophenol complexes and their structural elucidation. • Geometry optimization for structural verification utilizing DFT calculation. • Biomedical applications against pathogens, free radicals and carcinoma cell lines. • Molecular docking studies for confirmation of pharmaceutical applications. Coordination compounds of Ag(I), Cu(II), Ni(II), Fe(III) and VO (II) ions were synthesized from the ligand 2-(((9H-purin-6-yl)imino)methyl)-4-bromophenol (ABS). Microanalysis, magnetic susceptibility, infrared spectroscopy, Ʌ m calculation, and thermal analysis were utilized to inspect the structure of the investigated complexes. As per the data collected, the constitution of the 1:1 cation–adenine imine ligand was found for ABSVO, ABSNi, ABSCu, ABSAg and 1:2 for ABSFe complex. The structural formula for the examined compounds was refined using DFT simulations. The DFT/B3LYP approach was used to calculate the energy gaps and other critical theoretical factors. Moreover, the experimental behavior of the described molecules towards Escherichia coli's glucosamine-6-phosphate synthase (PDB ID: 2vf5), Aspergillus flavus' urate oxidase (PDB ID: 3cku), and the breast cancer oxidoreductase receptor site was rationalized using molecular docking (PDB ID: 3HB5). The hydrogen bonding energies of docked specific receptors were estimated and examined. Furthermore, the inspected metal chelates were subjected to in vitro antibacterial, antifungal, antioxidant and cytotoxicity studies. ABSCu complex showed significant cell growth inhibition activity (IC50 = 5.04 ± 0.07 µg/mL), even higher than the standard anticancer drugs; cisplatin (IC50 = 5.71 ± 0.55 µg/mL) versus breast carcinoma cells. [ABSTRACT FROM AUTHOR]